Skip to main content
Log in

Pioglitazone treatment in Cushing’s disease

  • Letter to the Editor
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Cannavò S, Ambrosi B, Chiodini I, et al. Baseline and CRH-stimulated ACTH and cortisol levels after administration of the peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone, in Cushing’s disease. J Endocrinol Invest 2004, 27: RC8–11.

    PubMed  Google Scholar 

  2. Theocharis S, Margeli A, Kouraklis G. Peroxisome Proliferator Activated Receptor-Gamma Ligands as Potent Antineoplastic Agents. Curr Med Chem Anti-Cancer Agents 2003, 3: 239–51. Accepted November 8, 2004.

    Article  CAS  Google Scholar 

  3. Heaney AP, Fernando M, Yong WH, Melmed SM. Functional PPAR-γ receptor is a novel therapeutic target for ACTH — secreting pituitary adenomas. Nat Med 2002, 8: 1281–7.

    Article  CAS  PubMed  Google Scholar 

  4. Aronoff S, Rosenblatt S, Braithwaite S, et al. Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6 — month randomised placebo-controlled dose-response study. Diabetes Care 2000, 23: 1605–11.

    Article  CAS  PubMed  Google Scholar 

  5. Ambrosi B, Dall’Asta C, Cannavo S, et al. Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing’s disease. Eur J Endocrinol 2004, 151: 173–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barbaro, D., Lapi, P., Orsini, P. et al. Pioglitazone treatment in Cushing’s disease. J Endocrinol Invest 28, 388–389 (2005). https://doi.org/10.1007/BF03347209

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347209

Keywords

Navigation